Diabetes News and Research

Latest Diabetes News and Research

Metabolic syndrome risk for veterans with post-traumatic stress disorder

Veterans with post-traumatic stress disorder (PTSD) are more likely to have metabolic syndrome than veterans without PTSD.

7 Jan 2009

Gene marker may improve odds of stem cell therapies for disease

A single tumor-suppressor gene may provide a unique marker for senescence in Mesenchymal stem cells (MSCs) in vitro, while also playing a role in moving MSCs into senescence, researchers at the Human Health Foundation and the Sbarro Institute for Cancer Research and Molecular Medicine report.

7 Jan 2009

Fighting childhood obesity should be a family affair

Fighting childhood obesity, which is a serious concern in our country, should be looked upon as a family affair.

7 Jan 2009

Lilly receives complete response letter for Olanzapine LAI for treatment of schizophrenia

Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.

7 Jan 2009

Discovery of more efficient way to create induced Pluripotent Stem (iPS) cells

A Boston University School of Medicine-led research team has discovered a more efficient way to create induced Pluripotent Stem (iPS) cells, derived from mouse fibroblasts, by using a single virus vector instead of multiple viruses in the reprogramming process.

7 Jan 2009

Adolescents with arthritis need more information when transitioning to adult care

Helping adolescents with arthritis develop the skills and secure resources to assure that their health care needs are met as they transition to adulthood is an important issue in the U.S. In general, the frequency of which young people with special health care needs receive transition services is low and, to date, no studies have examined this frequency.

7 Jan 2009

Control of blood vessels a possible weapon against obesity

Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet. Scientists now hope to learn how to control blood vessel development in humans in order to combat obesity and diabetes.

7 Jan 2009

Every 3 minutes one person is diagnosed with diabetes

According to new research from Britain every three minutes one person in the UK is diagnosed with diabetes - these latest figures come from the leading health charity Diabetes UK and marks the organisation's 75th Anniversary.

7 Jan 2009

Exercise may not be key to obesity epidemic

A recent international study fails to support the common belief that the number of calories burned in physical activity is a key factor in rising rates of obesity.

6 Jan 2009

People with Ala12 gene variant need to watch out for high fat in their diets

New evidence in mice bolsters the notion that a version of a gene earlier shown to protect lean people against weight gain and insulin resistance can have the opposite effect in those who eat a high-fat diet and are heavier, reveals a report in the January 7th issue of the journal Cell Metabolism, a Cell Press publication.

6 Jan 2009

New hope for leptin as a solution to obesity

The discovery more than a decade ago of leptin, an appetite-suppressing hormone secreted by fat tissue, generated headlines and great hopes for an effective treatment for obesity.

6 Jan 2009

Implantable cardioverter defibrillators improve survival in older heart patients

Implantable cardioverter defibrillators (ICDs) can improve survival in patients with heart damage - even those in their 70s - according to research reported in Circulation: Cardiovascular Quality and Outcomes.

6 Jan 2009

COUP-TFII plays pivotal role in obesity, metabolic syndrome

A protein known to play a role in development and the formation of organs is also an important factor in the control of obesity and diabetes, said researchers from Baylor College of Medicine in a report that appears in the current issue of the journal Cell Metabolism.

6 Jan 2009

Caring for chronic diseases in a "fragmented" health care system

Ed Wagner, MD, MPH, knew there had to be a better way. He and Group Health colleagues set out 15 years ago to explore how best to engage patients with chronic diseases in effective care.

6 Jan 2009

Hepatitis B and C in U.S.

In the last decade, more than 60,000 patients in the United States were asked to get tested for hepatitis B virus (HBV) and hepatitis C virus (HCV) because health care personnel in settings outside hospitals failed to follow basic infection control practices, according to a new study by the CDC.

6 Jan 2009

Novel treatment option for obesity

A new study in the January 7th issue of Cell Metabolism , a Cell Press publication, helps to explain why obese people and animals fail to respond to leptin, a hormone produced by fat that signals the brain to stop eating.

6 Jan 2009

Research initiative looks at helpful bacteria found on the skin

The study of ancient microbes may not seem consequential, but such pioneering research at the University of Oklahoma has implications for the state of modern human health.

5 Jan 2009

The impact of substance use disorders on medical expenditures for Medicaid beneficiaries with behavioral health disorders

People with substance abuse disorders cost Medicaid hundreds of millions of dollars annually in medical care, suggesting that early interventions for substance abuse could not only improve outcomes but also save substantial amounts of money, according to a comprehensive study that examined records of nearly 150,000 people in six states.

5 Jan 2009

Females of all ages are less active than their male peers

Two studies, presented (Tuesday 6 January) at a major academic conference, reveal the gender difference in activity levels among school children and the over 70s. Both studies show males to be more physically active than females.

5 Jan 2009

Phase 3 trial begins for Gammagard liquid plus rHuPH20 in primary immunodeficiency patients

Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).

From Baxter International Inc. 5 Jan 2009